San Francisco, CA, United States of America

Aileen Kelly

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Nurix Therapeutics, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aileen Kelly. Retrieved from https://idiyas.com/inventor/aileen-kelly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aileen Kelly: Innovator in Biopharmaceuticals

Introduction

Aileen Kelly is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that target specific pathways in disease treatment. Her innovative work has garnered attention in the scientific community.

Latest Patents

Aileen Kelly holds 1 patent for her invention titled "Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway." This patent relates to compounds that are useful for degrading BTK through a ubiquitin proteolytic pathway. The disclosure also includes pharmaceutically acceptable compositions comprising these compounds and methods for using them in the treatment of various diseases, conditions, or disorders.

Career Highlights

Aileen is currently employed at Nurix Therapeutics, Inc., where she continues to advance her research and development efforts. Her work at Nurix Therapeutics focuses on innovative therapeutic solutions that address unmet medical needs.

Collaborations

Aileen collaborates with notable professionals in her field, including her coworker Arthur T. Sands. Their combined expertise contributes to the advancement of biopharmaceutical research and development.

Conclusion

Aileen Kelly's contributions to the field of biopharmaceuticals exemplify her dedication to innovation and improving patient outcomes. Her work continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…